PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Management of Cold Chains will be Critical for the Growth of the Healthcare Industry Finds IMARC Group - Although it’s clear that the market for healthcare products are poised for robust growth, a strong and reliable cold chain logistics infrastructure will be critical for the sector’s development - IMARCgroup.com
Management of Cold Chains will be Critical for the Growth of the Healthcare Industry Finds IMARC Group

 

NewswireToday - /newswire/ - Noida, Uttar Pradesh, India, 2012/04/19 - Although it’s clear that the market for healthcare products are poised for robust growth, a strong and reliable cold chain logistics infrastructure will be critical for the sector’s development - IMARCgroup.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Imagine a truck carrying extremely temperature sensitive vaccines during the summer months of India when day temperatures can exceed 40-45°C. If such a vehicle has to cross a state border, it may take anywhere between a few to 24 hours to enter the next state. If the vehicle doesn’t have the provisions to store and maintain these vaccines at their ideal temperature levels (generally 2-8°C) then such a scenario would render them completely useless and even worse, will lead to serious health problems to the patient that is being administered that vaccine. Not just vaccines, but almost all biopharmaceuticals and a significant amount of clinical trial materials are extremely temperature sensitive, and as a result, have well defined needs for packaging, storage and transportation.

A recent report released by IMARC Group (imarcgroup.com), one of the worlds’s leading research and advisory firms, reveals that while it’s clear that the market for healthcare products is poised for robust growth, a strong and reliable cold chain logistics infrastructure will be critical for the sectors development. The report which has done a comprehensive analysis on the global healthcare cold chain logistics industry, expects this market to reach revenues worth US$ 9.5 Billion by 2016.

The report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)” provides an analytical and statistical insight into the logistic opportunities in the global healthcare market. The study that has been undertaken using both desk based as well as qualitative primary market research has analyzed three aspects of the global healthcare cold chain logistics market.

The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.

Key Questions Answered in This Report:

• What are the key factors driving the growth of the global healthcare cold chain logistics market?
• What are the challenges faced by the global healthcare cold chain logistics market?
• What is the total size and breakup of the global healthcare cold chain logistics market?
• What is the current and future size of healthcare cold chain products?
• What are the current and future cold chain opportunities in the global biopharmaceutical market?
• What are the current and future cold chain opportunities in the global vaccines market?
• What are the current and future cold chain opportunities in the global clinical trials market?
• What are the various methods used for cold chain packaging and transportation?
• What are the total costs involved in cold chain logistic services and how is it different from non-cold chain logistic services?
• Which regional markets will show the highest growth in the coming years?
• Which cold chain healthcare segments will show the highest growth in the coming years?
• Who are the key players in the global healthcare cold chain logistics market?

What we have achieved in this report:

Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:
Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Materials

Focus of the Analysis in Each Class:
• Drivers and challenges
• Historical sales trends
• Logistic requirements
• Impact of temperature excursions
• Opportunities in cold chain services
• Market outlook (2011-2016).

Understanding the Operations of a Healthcare Cold Chain Distribution Process

Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages;
• Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions;
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation;
• Understanding the key steps required in the setting and organization of an efficient cold chain distribution process.

Comprehensive Analysis of the Healthcare Cold Chain Logistic Services Market

Focus of the analysis:
• Quantifying the global healthcare cold chain logistic services market;
• Quantifying the market size by product;
• Quantifying the market size by service;
• Quantifying the market size by region.

Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
E: apac[.]imarcgroup.com - P: +91-120-425-6531

IMARC Group North America
E: america[.]imarcgroup.com - P: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
E:ema[.]imarcgroup.com - P: +44-702-409-7331

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Management of Cold Chains will be Critical for the Growth of the Healthcare Industry Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099 press[.]imarcgroup.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)